4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-N-propyl-benzenesulfonamide

ID: ALA120183

Chembl Id: CHEMBL120183

PubChem CID: 10861208

Max Phase: Preclinical

Molecular Formula: C18H20N4O2S

Molecular Weight: 356.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN(c1ccnn1-c1ccccc1)S(=O)(=O)c1ccc(N)cc1

Standard InChI:  InChI=1S/C18H20N4O2S/c1-2-14-21(25(23,24)17-10-8-15(19)9-11-17)18-12-13-20-22(18)16-6-4-3-5-7-16/h3-13H,2,14,19H2,1H3

Standard InChI Key:  ICXQTQDYWSHSOZ-UHFFFAOYSA-N

Associated Targets(Human)

CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C18 Tchem Cytochrome P450 2C18 (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 356.45Molecular Weight (Monoisotopic): 356.1307AlogP: 3.06#Rotatable Bonds: 6
Polar Surface Area: 81.22Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.45CX LogP: 2.91CX LogD: 2.91
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -1.69

References

1. Ha-Duong NT, Dijols S, Marques-Soares C, Minoletti C, Dansette PM, Mansuy D..  (2001)  Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.,  44  (22): [PMID:11606127] [10.1021/jm010861y]

Source